BEFORE THE FIRST DOSE: WHY SPERM BANKING MUST BE PART OF EVERY CANCER CARE PLAN

Introduction

Cancer is an emotionally and physically overwhelming diagnosis that prompts immediate action. Yet, in the urgency to begin treatment, essential conversations about fertility preservation are often overlooked. For men of reproductive age, cancer therapies such as chemotherapy, radiation, and surgery can have devastating effects on spermatogenesis and future fertility. Sperm cryopreservation prior to initiating therapy offers a straightforward, effective, and scientifically validated means of preserving the potential for biological fatherhood.

This blog explores why sperm banking must be integrated into every male cancer care plan from the outset. Drawing on clinical guidelines, recent studies, and ethical considerations, we make the case for fertility preservation as not just a medical option, but a fundamental patient right.

The Effect of Cancer and Its Treatments on Male Fertility

Male fertility depends on the integrity of the hypothalamic-pituitary-gonadal (HPG) axis, testicular tissue, and sperm production. Unfortunately, cancer and its treatments can impair one or more of these components:

Chemotherapy: Alkylating agents (e.g., cyclophosphamide, busulfan) are known gonadotoxins. These agents damage rapidly dividing spermatogenic cells and may lead to oligospermia or azoospermia. Damage can be temporary or permanent, depending on the dose and patient factors (Meistrich & Shetty, 2003).
Radiation Therapy: Radiation directed at or near the testes can harm germ cells. Even low doses (as little as 0.1 Gy) can impair spermatogenesis. Higher doses (>4 Gy) may result in permanent infertility (Rowley et al., 1974).
Surgery: Procedures involving the testicles, retroperitoneum, or pituitary gland can disrupt fertility. For example, retroperitoneal lymph node dissection (RPLND) can damage nerves critical to ejaculation, while orchiectomy removes sperm-producing tissue entirely.
The Cancer Itself: Testicular cancer and hematologic malignancies like Hodgkin lymphoma can impair spermatogenesis even before treatment begins. In some studies, up to 50% of men with newly diagnosed testicular cancer have abnormal semen parameters at diagnosis (Huyghe et al., 2004).

Given these risks, it is essential that discussions about fertility preservation occur immediately upon diagnosis.

Sperm Banking: A Proven Strategy

Sperm cryopreservation is the gold standard for fertility preservation in men. The process involves collecting semen—typically via masturbation—analyzing and processing it in a laboratory, and freezing it for long-term storage in liquid nitrogen (-196°C). It is:

Non-invasive and widely available
Highly effective: Cryopreserved sperm can be used for intrauterine insemination (IUI), in vitro fertilization (IVF), or intracytoplasmic sperm injection (ICSI), depending on quality.
Time-efficient: Collection and freezing can often be completed within 1–2 days.

Even a single ejaculate, if banked before treatment, can provide viable sperm for future reproductive use. While sperm parameters may vary between samples, studies show that over 50% of motile sperm typically survive the freeze-thaw process (Bahadur et al., 2002).

Timing is Everything: Before Treatment Begins

Sperm banking should ideally be performed before the initiation of any gonadotoxic treatment. This timing is critical because:

Sperm quality can decline rapidly after the first dose of chemotherapy or radiation.
Banking prior to treatment maximizes the likelihood of preserving viable, genetically intact sperm.
Post-treatment options are often more invasive, uncertain, and experimental (e.g., testicular sperm extraction).

Clinics that specialize in oncofertility can often expedite appointments, enabling collection and cryopreservation in as little as 24 to 48 hours.

Professional Guidelines: A Clear Mandate

Leading professional societies strongly advocate for early fertility discussions and referrals:

American Society of Clinical Oncology (ASCO): ASCO's guideline recommends that "as early as possible before treatment starts, oncologists should address the possibility of infertility with patients of reproductive age and be prepared to discuss fertility preservation options or refer to reproductive specialists" (Lee et al., 2006).
American Society for Reproductive Medicine (ASRM): ASRM considers sperm banking a standard of care and ethical obligation for male patients undergoing potentially sterilizing treatments.
National Comprehensive Cancer Network (NCCN): NCCN Guidelines for Adolescent and Young Adult Oncology include fertility preservation as a core component of comprehensive cancer care.

Despite these guidelines, a significant proportion of men report not being informed about fertility risks or preservation options before treatment.

Barriers to Timely Sperm Banking

Several barriers prevent sperm banking from being implemented universally:

Lack of Awareness: Many oncologists do not routinely discuss fertility preservation. A 2014 study showed that only 61% of U.S. oncologists always or often referred male patients for fertility preservation (Forman et al., 2014).
Time Constraints: In urgent cases, providers may prioritize immediate treatment over preservation. However, rapid sperm banking protocols exist for these situations.
Cost: In many states, insurance does not cover sperm banking or storage. The out-of-pocket cost can range from $500 to $1,000 for initial processing, plus annual storage fees.
Emotional Distress: Patients and families may feel overwhelmed by the diagnosis and may deprioritize future fertility in the face of life-threatening illness.
Cultural and Ethical Considerations: Religious beliefs, age, or personal circumstances may influence a patient’s decision about sperm banking.

Ethical Considerations: Reproductive Autonomy and Equity

Failing to inform patients about the option of fertility preservation can have serious ethical implications:

Autonomy: Patients deserve the opportunity to make informed decisions about their reproductive future.
Equity: All patients—regardless of race, age, or socioeconomic status—should have equal access to preservation services.
Psychological Well-being: Loss of fertility can have long-term psychosocial consequences. In survivorship, some patients experience grief, regret, or depression linked to infertility.

Providers must ensure that conversations about sperm banking occur early and are documented. Multidisciplinary teams, including oncologists, urologists, reproductive endocrinologists, and counselors, can help ensure consistent, compassionate care.

Late Referrals: Is It Ever Too Late?

Although the best time to bank sperm is before treatment, options may still exist afterward:

Post-treatment ejaculation: Some patients may regain spermatogenesis after therapy, especially if low-risk agents were used. Semen analysis should be repeated 6-12 months after treatment.
Testicular Sperm Extraction (TESE): In cases of post-treatment azoospermia, sperm may be retrieved directly from testicular tissue.
Experimental Therapies: Research into spermatogonial stem cell transplantation and in vitro spermatogenesis may eventually offer options for those with no viable sperm.

However, these options are often more complex, invasive, and expensive than pre-treatment sperm banking.

Innovations in Cryopreservation and Storage

Advancements continue to improve the effectiveness and accessibility of sperm banking:

Vitrification: A faster freezing technique that may enhance sperm survival.
At-home collection kits: Allow patients to collect samples privately and ship them to labs, although rapid processing is critical for viability.
Storage duration: Cryopreserved sperm remains viable for decades. Pregnancies have been achieved with sperm stored for over 20 years.

Case Studies and Real-World Impact

The human impact of sperm banking is best illustrated through stories:

A 25-year-old man diagnosed with Hodgkin lymphoma banked sperm before chemotherapy. Five years later, he and his partner used ICSI to conceive their first child.
A teenager with leukemia was not offered sperm banking and is now infertile. His parents express profound regret that the conversation never occurred.

These cases underscore both the power of timely preservation and the consequences of missed opportunities.

Conclusion: Make Fertility Preservation the Standard, Not the Exception

Sperm banking is a scientifically sound, ethically mandated, and logistically feasible component of comprehensive cancer care for men. The evidence is clear: fertility preservation improves long-term quality of life and empowers patients to envision a future beyond cancer.

Healthcare systems must ensure that all male patients are counseled on fertility risks and offered sperm banking before the first dose of treatment. Doing so not only honors clinical guidelines, but respects the human desire for family, continuity, and hope.

References

Bahadur, G., Ling, K. L., Hart, R., Ralph, D., Wafa, R., & Ashraf, A. (2002). Semen quality and cryopreservation in adolescent cancer patients. Human Reproduction, 17(12), 3157–3161.

Forman, E. J., Anders, C. K., & Behera, M. A. (2010). National survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. Fertility and Sterility, 94(5), 1652–1656.

Huyghe, E., Matsuda, T., & Thonneau, P. (2004). Increasing incidence of testicular cancer worldwide: a review. The Journal of Urology, 170(1), 5-11.

Lee, S. J., Schover, L. R., Partridge, A. H., Patrizio, P., Wallace, W. H. B., Hagerty, K., ... & Oktay, K. (2006). American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. Journal of Clinical Oncology, 24(18), 2917-2931.

Meistrich, M. L., & Shetty, G. (2003). Hormonal suppression for fertility preservation in males and females. Reproduction, 125(6), 433-445.

Rowley, M. J., Leach, D. R., Warner, G. A., & Heller, C. G. (1974). Effect of graded doses of ionizing radiation on the human testis. Radiation Research, 59(3), 665-678.

Please contact us with questions